Full Product Name
Rabbit anti-Homo sapiens (Human) PAFAH1B1 Polyclonal antibody
Alternative Names
LIS 1 antibody; LIS 2 antibody; LIS-1 antibody; LIS1 antibody; LIS1_HUMAN antibody; LIS2 antibody; Lissencephaly 1 protein antibody; Lissencephaly-1 protein antibody; MDCR antibody; MDS antibody; PAF acetylhydrolase 45 kDa subunit antibody; PAF AH 45 kDa subunit antibody; PAF AH alpha antibody; PAF-AH 45 kDa subunit antibody; PAF-AH alpha antibody; PAFAH alpha antibody; PAFAH antibody; PAFAH1B1 antibody; PAFAHA antibody; Platelet activating factor acetylhydrolase 1b regulatory subunit 1 antibody; Platelet activating factor acetylhydrolase isoform Ib alpha subunit antibody; Platelet-activating factor acetylhydrolase IB subunit alpha antibody
Immunogen
Recombinant Human Platelet-activating factor acetylhydrolase IB subunit alpha protein (40-155AA)
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated
The PAFAH1B1 Antibody (Product code: CSB-PA017383LA01HU) is Non-conjugated. For PAFAH1B1 Antibody with conjugates, please check the following table.
Available Conjugates
Conjugate |
Product Code |
Product Name |
Application |
HRP |
CSB-PA017383LB01HU |
PAFAH1B1 Antibody, HRP conjugated |
ELISA |
FITC |
CSB-PA017383LC01HU |
PAFAH1B1 Antibody, FITC conjugated |
|
Biotin |
CSB-PA017383LD01HU |
PAFAH1B1 Antibody, Biotin conjugated |
ELISA |
Purification Method
>95%, Protein G purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
Tested Applications
ELISA, IF
Recommended Dilution
Application |
Recommended Dilution |
IF |
1:50-1:200 |
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
Usage
For Research Use Only. Not for use in diagnostic or therapeutic procedures.